Private
In an effort to reduce shortages and the reliance on foreign medical supply chains, the Biomedical Advanced Research and Development Authority (BARDA) and Department of Defense (DoD) have teamed up with Corning, Inc. to produce more glass tubing and vials quicker.
In particular, the federal... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) initiated a partnership with digital health developer Empatica last week that focuses on developing a wearable system and algorithm that can detect early signs of COVID-19 infection in individuals.
That system, known as Aura,... Read More »
Department of Health and Human Services (HHS) and Department of Defense (DOD) officials said the agencies have partnered to expedite vial manufacturing capacity amid the COVID-19 pandemic.
Through Operation Warp Speed, the Biomedical Advanced Research and Development Authority (BARDA), under the... Read More »
The lack of a cohesive national plan for dealing with COVID-19 was once more brought to the fore last week with the release of a report from the Johns Hopkins Center for Health Security, which laid out a series of recommendations surrounding antibody studies.
These antibody studies --... Read More »
Emergent BioSolutions revealed this week plans to expand its viral vector and gene therapy capabilities.
The company announced it will invest $75 million in its Canton, Mass., facility, which is focused on the contract development and manufacturing (CDMO) of drug substances for live viral... Read More »
The First Responder Network Authority (FirstNet) Board of Directors has approved more than $200 million for network upgrades that include 5G and on-demand coverage.
“These investments mark the next major step in our mission as we continue to evolve the FirstNet network based on public... Read More »
The National Science Foundation (NSF) is providing a team of Toledo, Ohio-based Battelle researchers with funding earmarked for wastewater virus research.
“This should give us a reflection of what’s going on in specific neighborhoods,” Battelle Principal Research Scientist Rachel Spurbeck,... Read More »
The Senate voted to support GAVI, the Vaccine Alliance, this week through a resolution introduced by U.S. Sens. Marco Rubio (R-FL) and Time Kaine (D-VA).
The resolution commends and reaffirms support for GAVI. It also puts the nation’s money where its mouth is, so to speak, pledging U.S.... Read More »
In exchange for rapidly testing drugs for potential repurposing as COVID-19 treatments, University of Maryland School of Medicine (UMSOM) researchers will receive up to $3.6 million from the Defense Advanced Research Projects Agency (DARPA) over the next year.
All of the drugs to be tested are... Read More »
Results from a University of Oxford study found that the low-cost, low-dose steroid dexamethasone was revealed this week to have reduced COVID-19 deaths by up to one third in patients hospitalized with the disease.
This is the first time a therapy has demonstrated any ability to improve survival... Read More »
Tamr Government Solutions, based in Cambridge, Mass., has received the Department of Homeland Security (DHS) Science and Technology Directorate’s (S&T) inaugural Phase 5 award to develop an international traveler screening solution.
The $813,000 funding allotment via the Silicon Valley... Read More »
Raytheon Missiles & Defense personnel are espousing the benefits of the successful initial guided release of a StormBreaker smart weapon from an F/A-18E/F Super Hornet.
"StormBreaker is the only weapon that enables pilots to hit moving targets during bad weather or if dust and smoke are in the... Read More »
Pharmaceutical company SIGA Technologies, Inc. gained a boost to its work toward a label expansion for TPOXX, an antiviral drug for treating smallpox caused by variola virus, thanks to an increase in funding from the U.S. Department of Defense (DoD) this week.
With the addition, DoD is now... Read More »
Biotechnology company Regeneron has begun clinical trials of its REGN-COV2 cocktail, a two-antibody therapeutic for COVID-19, with recent funding from the Biomedical Advanced Research and Development Authority (BARDA).
The therapeutic proposes to inhibit SARS-CoV-2, the virus that causes... Read More »
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational COVID-19 vaccine.
The trial is expected to commence in the second half of July, moved up from its initial September time frame.... Read More »
Under the terms of a new contract, Bavarian Nordic will manufacture and deliver additional cases of the MVA-BN Filo vaccine in bulk to Janssen Vaccines & Prevention B.V., building its supply of Ebola vaccines.
The deal, valued $13.9 million, will kick off this year and build on the more than 2... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Snapdragon Chemistry are teaming up to develop a continuous manufacturing platform to produce a specific raw material for COVID-19 vaccines.
They are developing ribonucleotide triphosphates (NTPs), a critical raw material for... Read More »
Regeneron Pharmaceuticals initiated the first clinical trial of REGN-COV2, an antibody cocktail for the prevention and treatment of COVID-19.
The REGN-COV2 clinical program will consist of four separate study populations, including hospitalized COVID-19 patients, non-hospitalized symptomatic... Read More »
Health experts maintain the federal government needs to craft a plan to distribute COVID-19 vaccines in Black and Latino that have borne the brunt of the pandemic nationwide.
“They are going to have to make sure we have a sound distribution plan to make sure that we don’t repeat the mistakes... Read More »
Testing of Moderna’s mRNA-1273 COVID-19 vaccine candidate moved forward this week, with the announcement that arrangements are being made to study 30,000 subjects as part of a phase 3 study in July and manufacturing set to reach as high as 1 billion 100 microgram doses per year in... Read More »
Emergent BioSolutions Inc. announced Thursday it signed an agreement to provide its contract development and manufacturing (CDMO) services to support AstraZeneca's COVID-19 vaccine candidate in the United States.
The agreement, valued at approximately $87 million, gives Emergent stateside... Read More »
Another SARS-CoV-2 laboratory diagnostic has caught the attention of the Biomedical Advanced Research and Development Authority (BARDA), which is teaming up with OraSure Technology, Inc. to get it United States Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
This test,... Read More »
For three years, the Biomedical Advanced Research and Development Authority (BARDA) has supported the development of Chembio Diagnostics’ DPP Zika IgM System diagnostic system, and now, the result has been approved for marketing by the U.S. Food and Drug Administration.
The test detects... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and the Defense Advanced Research Projects Agency (DARPA) have reached an interagency agreement with AstraZeneca to support phase 1 clinical development of a monoclonal antibody combination therapy for use against COVID-19.
This... Read More »
The University of Queensland (UQ) has partnered up with CSL and the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate development, manufacturing, and distribution of a COVID-19 vaccine candidate its researchers pioneered earlier this year.
In an agreement formalized this week,... Read More »
Results are in from the phase 1 human trial of the Bavarian Nordic A/S vaccine candidate MVA-BN WEV, a prophylactic meant for use against three equine encephalitis viruses, and the data paints the picture of a well-tolerated vaccine capable of spurring immune responses.
The vaccine is meant to... Read More »
FLIR Systems officials said the company has developed software for its T-Series, Exx-Series, and A-Series thermal imaging cameras to perform COVID-19 elevated skin temperature screenings in high-traffic areas.
Officials said the process via FLIR Screen-EST can be conducted in two seconds or less... Read More »
RAND Corp. recently developed an analytical tool that can be used to predict the regional risks of importing cases of COVID-19.
The tool can be used by policymakers to mitigate the threat to public health.
The COVID-19 Air Traffic Visualization tool uses International Air Transport... Read More »
A coalition of AbbVie, Harbour BioMed (HBM), Utrecht University (UU), and Erasmus Medical Center (EMC) have joined together to create a monoclonal antibody therapy that could hold the key to preventing and treating COVID-19, through its viral cause: SARS-CoV-2.
The therapeutic is based on a... Read More »
As part of an expansion to their existing partnership, the Biomedical Advanced Research and Development Authority (BARDA) and MODERNATX, Inc. will increase the domestic manufacturing capacity of the mRNA-1273 vaccine, a candidate to stop the spread of COVID-19.
The relationship has been ongoing... Read More »
Bell Textron Inc., has reached agreements with nine aerospace industry firms to form Team Invictus, which will produce the Bell 360 Invictus prototype for the U.S. Army.
“Team Invictus is working together to show how cutting-edge technology will give soldiers the ability to confidently operate... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) announced it would bring $383 million to a new partnership with AstraZeneca this week to guarantee 300 million globally accessible doses of the company’s AZD1222 vaccine candidate for COVID-19.
That vaccine still has to be proven safe... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to develop a Chikungunya vaccine, providing as much as $14.1 million for manufacturing and clinical development.
On the line is a two-dose,... Read More »
First responders and healthcare workers stand to benefit from a new partnership between the Biomedical Advanced Research and Development Authority (BARDA) and Evidation Health, which are sifting through data from wearable devices to create an early warning algorithm for COVID-19 symptoms.
This... Read More »
Hollingsworth & Vose has secured a $2.2 million Department of Defense (DoD) contract to increase domestic ventilator and respirator production.
The effort involves producing 27.5 million N95 filters, and 3.1 million N95 respirators per monthly, beginning in August. The endeavor is in support of... Read More »
